ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 2 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,962,563 | -8.5% | 372,155 | -27.5% | 0.80% | -6.2% |
| Q2 2023 | $200,031,261 | -2.2% | 513,256 | -6.5% | 0.85% | -15.1% |
| Q1 2023 | $204,554,617 | +5.8% | 549,022 | +7.5% | 1.01% | -14.7% |
| Q4 2022 | $193,427,567 | +6.8% | 510,592 | -0.5% | 1.18% | +2.0% |
| Q3 2022 | $181,133,000 | -8.6% | 513,052 | -1.9% | 1.16% | -3.3% |
| Q2 2022 | $198,086,000 | +18.7% | 522,821 | -1.2% | 1.20% | +37.5% |
| Q1 2022 | $166,870,000 | +150.5% | 529,224 | +178.2% | 0.87% | +150.7% |
| Q4 2021 | $66,616,000 | – | 190,229 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |